Department of Physiology and Biophysics, The University of Mississippi Medical Center, Jackson, Mississippi; and Department of Biochemistry, The University of Mississippi Medical Center, Jackson, Mississippi.
Department of Physiology and Biophysics, The University of Mississippi Medical Center, Jackson, Mississippi; and.
Am J Physiol Regul Integr Comp Physiol. 2014 Oct 1;307(7):R769-77. doi: 10.1152/ajpregu.00132.2014. Epub 2014 Jun 4.
The heme oxygenase system has long been believed to act largely as a housekeeping unit, converting prooxidant free heme from heme protein degradation into the benign bilirubin for conjugation and safe excretion. In recent decades, however, heme oxygenases have emerged as important regulators of cardiovascular function, largely through the production of their biologically active metabolites: carbon monoxide, bilirubin, and elemental iron. Even more recently, a number of separate lines of evidence have demonstrated an important role for the heme oxygenases in the establishment and maintenance of pregnancy. Early preclinical and clinical studies have associated defects in the heme oxygenase with the obstetrical complication preeclampsia, as well as failure to establish adequate placental blood flow, an underlying mechanism of the disorder. Several recent preclinical studies have suggested, however, that the heme oxygenase system could serve as a valuable therapeutic tool for the management of preeclampsia, which currently has few pharmacological options. This review will summarize the role of heme oxygenases in pregnancy and highlight their potential in advancing the management of patients with preeclampsia.
血红素氧合酶系统长期以来被认为主要是一种管家单元,将来自血红素蛋白降解的促氧化剂游离血红素转化为结合和安全排泄的良性胆红素。然而,在最近几十年,血红素氧合酶已成为心血管功能的重要调节剂,主要通过其生物活性代谢产物的产生来实现:一氧化碳、胆红素和元素铁。甚至更近的一些独立证据表明,血红素氧合酶在妊娠的建立和维持中起着重要作用。早期的临床前和临床研究将血红素氧合酶的缺陷与产科并发症子痫前期以及未能建立足够的胎盘血流联系起来,这是该疾病的一个潜在机制。然而,几项最近的临床前研究表明,血红素氧合酶系统可以作为治疗子痫前期的有价值的治疗工具,目前这种疾病几乎没有药理学选择。这篇综述将总结血红素氧合酶在妊娠中的作用,并强调其在子痫前期患者管理中的潜在应用。